Abstract

We explored the preventative effect of Annona atemoya leaf (AAL) extract on memory impairment in a scopolamine (SCO)-induced cognitive deficit mouse model. Fifty-eight mice were randomly divided into six groups and orally treated with AAL extract at (50, 100, or 200 mg/kg) or tacrine (TAC) for 21 days. Memory deficits were induced by a single injection of 1 mg/kg SCO (i.p.) and memory improvement was evaluated by using behavioral tests such as the passive avoidance task and Y-maze test. The levels of cholinergic functions, neuronal cell death, reactive oxygen species, and protein expression related to hippocampal neurogenesis were examined by immunohistochemical staining and western blotting. The administration of AAL extract improved memory impairment according to increased spontaneous alternation in the Y-maze and step-through latency in passive avoidance test. AAL extract treatment increased the acetylcholine content, choline acetyltransferase, and acetylcholinesterase activity in the hippocampus of SCO-stimulated mice. In addition, AAL extract attenuated oxidative stress-induced neuronal cell death of hippocampal tissue. In terms of the regulatory mechanisms, AAL extract treatment reversed the SCO-induced decreases in the expression of Akt, phosphorylation of cAMP response element binding protein, and brain-derived neurotrophic factor. Our findings demonstrate that AAL extract has the ability to alleviate memory impairment through preventative effect on cholinergic system dysfunction and oxidative stress-related neuronal cell death in a SCO-induced memory deficit animal model. Overall, AAL may be a promising plant resource for the managing memory dysfunction due to neurodegenerative diseases, such as Alzheimer’s disease (AD).

Highlights

  • Dementia, which is characterized by aging-related memory and cognitive dysfunction and includes Alzheimer’s disease (AD), is becoming a more common public health problem as the lifespan of humans increases in modern industrial society [1,2]

  • These results suggest that atemoya leaf (AAL) extract may promote memory function through a mechanisms associated with the activation of neurogenic factors Brain Derived Neurotrophic Factor (BDNF)/CREB and survival protein Akt in the SCO-induced memory deficit mouse model

  • Cumulative evidence has suggested that cognitive dysfunction in AD is the result of impaired neurogenesis in the hippocampus of the adult brain, and it is crucial to identify novel drugs that can be used for the treatment of AD [27,28]

Read more

Summary

Introduction

Dementia, which is characterized by aging-related memory and cognitive dysfunction and includes Alzheimer’s disease (AD), is becoming a more common public health problem as the lifespan of humans increases in modern industrial society [1,2]. The number of individuals with these diagnoses is gradually increasing, no curative medical treatment for dementia has been developed or approved by the US Food and Drug Administration (FDA), and drugs for AD provide only symptom relief [3]. Various acetylcholinesterase (AChE) inhibitors, such as tacrine (TAC), donepezil, and rivastigmine, have been used as medications for AD patients [8]. All these drugs have limited effectiveness against AD due to their loss of efficacy and toxic side effects as the disease progresses [9,10,11]. Alternative and complementary therapies need to be developed for AD

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call